Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA)_(accepted_version)
Accepted author manuscript, 1.51 MB, PDF document
| Original language | English |
|---|---|
| Journal | The Lancet Respiratory Medicine |
| Volume | 8 |
| Issue number | 5 |
| Pages (from-to) | 493-505 |
| Number of pages | 13 |
| ISSN | 2213-2600 |
| DOIs | |
| Publication status | Published - 2020 |
ID: 241482401